Company / PP&E (Net)
Jaguar Health, Inc. PP&E (Net) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$463.0K
FY2025
5-year range
$463.0K / $710.2K
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 6 consecutive years, from $1M in FY2017 to $463,000 in FY2025.
Based on SEC 10-K filings.
$463,000 in FY2025 with a 10-year CAGR of -5.7%.
Declined from $557,000 to $463,000 over the past 3 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -7.3%
- 10-Year CAGR
- -5.7%
Key checks
Key Insights
- Jaguar Health, Inc.'s pp&e (net) has declined for 6 consecutive years.
- 5-year CAGR of -7.3%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 0.2% year-over-year.
- Peak pp&e (net) was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $463.0K | -0.2% |
| FY2024 | $464.0K | -16.7% |
| FY2022 | $557.0K | -17.7% |
| FY2020 | $677.0K | -4.7% |
| FY2019 | $710.2K | -6.6% |
| FY2018 | $760.6K | -37.8% |
| FY2017 | $1.2M | +37.9% |
| FY2016 | $885.9K | +6.8% |
| FY2015 | $829.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026